Ga‑emp‑100 pet/ct—a novel method for non‑invasive assessment of c‑met expression in non‑small cell lung cancer

HIGHLIGHTS

• who: Lena M. Unterrainer from the Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr15, Munich, Germany have published the paper: Gau2011EMPu2011100 PET/CTu2014a novel method for nonu2011invasive assessment of cu2011MET expression in nonu2011small cell lung cancer, in the Journal: (JOURNAL) of 23/08/2022

SUMMARY

The role of c-MET as member of the receptor tyrosine kinase superfamily in the signaling pathway of nonsmall cell lung cancer (NSCLC) has been extensively described. MET is overexpressed in up to 60% of NSCLC cases, and in tumors harboring MET mutations this molecular structure is . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.